Amphastar Pharmaceuticals, Inc.
AMPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001297184
In the last 90 days, Amphastar Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 227 institutions reported holding it in 13F filings for Q3 2026, worth $754.6M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 19, 2026
- $1.20B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $1.56M in total
- 5
- 13F holdersQ3 2026, +18 vs. previous quarter
- 227
- 13F valueReported value at the end of Q3 2026
- $754.6M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $719.9M
- −1.7% year over year
- Net income, FY2025
- $98.1M
- −38.5% year over year
- Free cash flow, FY2025
- $121.2M
- −29.7% year over year
- Revenue, Q3 FY2026
- $207.6M
- +8.2% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 4.26M
- Shares sold short
- Change
- −72.3K
- −1.7% vs. previous
- Days to cover
- 11.34
- At average daily volume
Superinvestors holding AMPH, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding AMPH at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Amphastar Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2026 (view filing)4:11 PM ET | Nov 16 | 2 days | Peters William JCFO, EVP & TREASURER | SSale | −11.0K | $29.99 | −$329.9K | −6.2%167.1K after | 10b5-1 |
| Nov 6, 2026 (view filing)4:17 PM ET | Nov 4-5 | 2 days | Peters William JCFO, EVP & TREASURER | SSale | −28.6K | $28.45 | −$814.7K | −14.6%167.1K after | 2 lots10b5-1 |
| Sep 23, 2026 (view filing)6:02 PM ET | Sep 21 | 2 days | Peters William JCFO, EVP & TREASURER | SSale | −4.14K | $25.00 | −$103.5K | −2.4%168.7K after | 10b5-1 |
| Sep 17, 2026 (view filing)6:19 PM ET | Sep 16 | 1 day | Zhou RongSENIOR EVP, PRODUCTION CENTER | SSale | −10.0K | $23.94 | −$239.4K | −5.6%169.2K after | |
| Sep 3, 2026 (view filing)7:42 PM ET | Sep 2 | 1 day | Zhou RongSENIOR EVP, PRODUCTION CENTER | SSale | −3.19K | $23.63 | −$75.3K | −1.8%169.2K after | |
| Aug 12, 2026 (view filing)6:14 PM ET | Aug 11 | 1 day | Prins Richard KDirector | SSale | −7.97K | $20.30 | −$161.9K | −21.2%29.6K after | |
| Aug 11, 2026 (view filing)4:57 PM ET | Aug 7 | 4 days | Peters William JCFO, EVP & TREASURER | SSale | −8.18K | $22.48 | −$183.9K | −4.5%172.8K after | 10b5-1 |
| Dec 18, 2025 (view filing) | Dec 17 | 1 day | Zhou RongSENIOR EVP, PRODUCTION CENTER | SSale | −9.79K | $26.20 | −$256.4K | −6.6%138.0K after | |
| Dec 15, 2025 (view filing) | Dec 11-12 | 4 days | Petersen Floyd F.Director | SSale | −4.16K | $25.82 | −$107.5K | −5.5%71.4K after | 2 lots |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Prins Richard KDirector | SSale | −4.18K | $27.10 | −$113.3K | −10.6%35.2K after |
Top 10 13F holders, Q3 2026
See all 227 holdersThe largest institutional positions in Amphastar Pharmaceuticals, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,118,737 | $132.1M | 0.00% | −106,197−2.0% | Reduced |
| Dimensional Fund Advisors LP | 2,382,991 | $61.5M | 0.01% | +77,884+3.4% | Added |
| State Street Corp | 1,674,060 | $43.2M | 0.00% | +31,934+1.9% | Added |
| American Century Companies Inc | 1,585,068 | $40.9M | 0.02% | +408,442+34.7% | Added |
| Vanguard Capital Management LLC | 1,239,347 | $32.0M | 0.00% | −242,605−16.4% | Reduced |
| Marshall Wace, LLP | 1,216,253 | $31.4M | 0.03% | +149,931+14.1% | Added |
| D. E. Shaw & Co., Inc. | 1,145,129 | $29.6M | 0.02% | +258,081+29.1% | Added |
| Geode Capital Management, LLC | 970,452 | $25.1M | 0.00% | +612+0.1% | Added |
| Fuller & Thaler Asset Management, Inc. | 922,964 | $23.8M | 0.07% | −26,274−2.8% | Reduced |
| Vanguard Portfolio Management LLC | 803,869 | $20.7M | 0.00% | −5,699−0.7% | Reduced |
Holders of 5% or more of AMPH
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Amphastar Pharmaceuticals, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Zhang Jack Y. | 13G/A | 24.80%12.5M shares | – | Feb 12, 20215 filings | Feb 7, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 11.50%5.33M shares | – | Oct 17, 20251 filing | Oct 17, 2025 | SEC |
| Dimensional Fund Advisors LP | 13G | 5.20%2.31M shares | New | Jul 14, 20261 filing | Jul 14, 2026 | SEC |